Royal Bank of Canada »

Neurocrine Biosciences shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2011-09-30 $43k 4.9k 8.62
2011-06-30 $19k 2.2k 8.62

More positions owned by Royal Bank of Canada

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Bk Nova Cad (BNS)
Enbridge (ENB)
Visa Com Cl A (V)

View all positions for Royal Bank of Canada

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Jpmorgan Chase & Co
Bellevue Group
Geode Capital Management
T. Rowe Price Associates
Morgan Stanley
Dodge & Cox
Invesco
AQR Capital Management
Goldman Sachs Group
Brown Advisory Holdings Incorporated
Armistice Capital

View all funds holding Neurocrine Biosciences